A suite of Griffith University research projectshavereceived more than $5 million in research funding today from the National Health and Medical Research Council.
Griffith’s NHMRC outcomes for Investigator Grants, Partnership Projects (2018 PRC3) and Development Grantstotalled$5,167,963.
“Warmestcongratulationsto the academic staff and their colleagues at other institutions who have achieved this success and many other staff within academic elements and central administration who have provided support,”Griffith Vice Chancellor and President, Professor Carolyn Evans said.
Dr Lauren Ball was awarded $1,526,912 for her Emerging Leadership Level 2 (EL2) Fellowship titled ‘Capitalisingon the Potential of the Primary Care Setting to Facilitate Healthy Eating in the Australian Population’, that will be hosted by the Menzies Health Institute Queensland, Griffith Sciences.
ProfessorMichael Good was awarded $1,501,595 for his Leadership Level 3 (L3) Fellowship titled ‘Novel Vaccine Technology to Translate Knowledge of Immuno-Pathogenesis into Vaccines and Therapeutics’, that will be hosted by the Institute forGlycomics.
Associate Professor Dianne Shanley, Professor Melanie Gimmer-Zembeck,ProfessorSheena Reilly,ProfessorRobert Ware, AssociateProfessorJoshua Byrnes,ProfessorSharyn Rundle-Thiele andProfessorAmanda Wheeler were awarded $1,070,761 for the project ‘A Tiered Approach to the Diagnosis of Fetal Alcohol Spectrum Disorder in Remote Indigenous Primary Care Settings’, that will be hosted by the Menzies Health Institute Queensland, Griffith Sciences.
Professor Suresh Mahalingam and Dr Adam Taylor were awarded $1,068,696 for the project:A New Vaccine to Protect Against Chikungunya Virus (and Similar Other Viruses) Causing Chronic Musculoskeletal Diseases’, that will be hosted by the Menzies Health Institute Queensland, Griffith Sciences.
Griffith University staff part of a team led by other institutions in a Development Grant
ProfessorMark vonItzstein(Institute forGlycomics) for the project ‘Breaking Antibiotic Resistance in High Priority Gram-Negative Sepsis Pathogens’ (APP1176180), withProfessorMark Walker from the University of Queensland, $1,067,778.